Capital Increase and Fundraising through a Third-Party Allotment of Stock Acquisition Rights with Exercise Price Adjustment Clauses
First written in FY2024-Q2. 2 of 4 entries say "Advanced", first in FY2024-Q3. Latest entry: FY2025.
2 other companies' latest entry also says "Achieved".
- FY2025AchievedAnnual report
「All stock acquisition rights were acquired and cancelled as of 2 December 2024.」
The acquisition and cancellation of all first-series stock acquisition rights with an exercise-price adjustment clause issued through a third-party allotment, including the outstanding rights, has been completed. - FY2024AdvancedAnnual report
「Number of shares delivered upon exercise during the period (shares) 670,000 1,140,000 Funds raised through exercises during the period (¥ million) 332 550」
Over the full year, 11,400 of the first series of stock acquisition rights with an exercise-price adjustment clause were exercised, resulting in the issuance of 1,140,000 shares and ¥550 million in financing. - FY2024-Q3AdvancedAnnual report
「Number of stock acquisition rights with exercise-price adjustment clauses, etc., exercised during the quarter (rights) 4,700 Number of shares delivered upon exercise during the quarter (shares) 470,000 Funds raised through exercises during the quarter (¥ million) 218」
Of the first series of stock acquisition rights with an exercise-price adjustment clause, 4,700 rights were exercised during the third quarter, resulting in the issuance of 470,000 shares and ¥218 million in financing. Share capital and the capital surplus each increased by ¥109 million as a result. In addition, 330,000 shares were issued by the filing date, bringing the total number of shares issued to 14,776,000. - FY2024-Q2First statedAnnual report
「Based on a resolution of the Board of Directors meeting held on 29 September 2023, the company issued its first series of stock acquisition rights through a third-party allotment on 17 October of the same year. The rights included provisions for exercise designation and suspension designation, as well as an exercise-price adjustment clause.」
The company issued 27,000 stock acquisition rights through a third-party allotment, representing 2,700,000 potential shares, with estimated net proceeds of ¥1,676,852,000. The initial exercise price was ¥623, the minimum exercise price was ¥437, and the exercise period ran from 18 October 2023 to 16 October 2026. By the filing date, 2,900 rights had been exercised, resulting in the issuance of 290,000 shares and an increase of ¥66 million each in share capital and the capital surplus.